1Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J,2004,25:1880-1890.
2Da-Yi HU, Chang-yu Pan, Jin-Ming, et al. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J,2006,27:2573-2579.
3Coutiubo M, Gerstein HC. The relationship between glucose and incident cardiovascular events. A meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12. 4 years. Diabetes Care, 1999,22 : 1385-1387.
4Heinig RE. The patient with diabetes: preventing cardiovascular complications, 2006,29( 10 Suppl) : 13-20.
5Bartnik M, Malmberg K. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J,2004,25:1990-1997.
6The DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet, 1999,354:617-621.
7The Diabetes Control and Complications Trim Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993,329:977-986.
8Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005,353:2643-2653.
9UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes ( UKPDS 34 ). Lancet, 1998,352: 854-865.
10Misson RT, Cutler RE. Radiocontrast-induced renal failure. West J Med,1985,142:657-664.
